These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 19414393)

  • 1. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.
    Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Carvalho R; Lopes C
    Prostate; 2002 Sep; 53(1):88-94. PubMed ID: 12210484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer.
    Chiang CH; Chen KK; Chang LS; Hong CJ
    J Urol; 2004 Apr; 171(4):1529-32. PubMed ID: 15017213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
    Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
    Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer.
    Yang Q; Shan L; Segawa N; Nakamura M; Nakamura Y; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2001; 21(1A):197-200. PubMed ID: 11299734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis.
    Yigit B; Bozkurt N; Narter F; Yilmaz H; Yucebas E; Isbir T
    Anticancer Res; 2007; 27(2):933-6. PubMed ID: 17465223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
    Schatzl G; Marberger M; Remzi M; Grösser P; Unterlechner J; Haidinger G; Zidek T; Preyer M; Micksche M; Gsur A
    Urology; 2005 Jun; 65(6):1141-5. PubMed ID: 15893813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci.
    Xue W; Irvine RA; Yu MC; Ross RK; Coetzee GA; Ingles SA
    Cancer Res; 2000 Feb; 60(4):839-41. PubMed ID: 10706090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New polymorphisms in the PSA promoter in patients with prostate carcinoma].
    Schostak M; Braun C; Krause H; Miller K; Kempkensteffen C; Hinz S; Strenziok R; Blana A; Schrader M
    Aktuelle Urol; 2007 Nov; 38(6):465-72. PubMed ID: 17987534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
    Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
    Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
    Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
    Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
    Kuasne H; Rodrigues IS; Fuganti PE; Losi-Guembarovski R; Ito K; Kishima MO; Rodrigues MA; Rogatto SR; Santos RM; Cólus IM
    Cancer Invest; 2010 Nov; 28(9):917-24. PubMed ID: 20632874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
    Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S; Diamandis EP
    Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
    Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
    Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
    Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
    Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.